Treatment of patients with refractory giardiasis

Clinical Infectious Diseases

Volumn 33, Issue 1, 2001, Pages 22-28

  Nash, Theodore E ^a   Ohl, Christopher A ^b   Thomas, Elaine ^c   Subramanian, Gangadnaran ^a,e   Keiser, Paul ^a   Moore, Thomas A ^d  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF NEW MEXICO   (United States)

^d UNIVERSITY OF KANSAS SCHOOL OF MEDICINE WICHITA   (United States)

^e CELERA GENOMICS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEPACRINE; METRONIDAZOLE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CLINICAL ARTICLE; DRUG EFFICACY; ELECTROIMMUNOASSAY; FEMALE; GIARDIA LAMBLIA; GIARDIASIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; MALE; PRIORITY JOURNAL; TREATMENT FAILURE;

ADULT; ANIMALS; ANTIPROTOZOAL AGENTS; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; FEMALE; GIARDIA LAMBLIA; GIARDIASIS; HUMANS; IMMUNOCOMPETENCE; IMMUNOCOMPROMISED HOST; MALE; METRONIDAZOLE; MIDDLE AGED; QUINACRINE;

EID: 0034984457     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/320886     Document Type: Article

References (60)

1. Giardiasis surveillance: United States, 1992-1997
2. The treatment of Giardia lamblia infection with mepacrine, metronidazole and furazolidone
3. Outbreak of giardiasis: Effect of a new antiflagellate drug, tinidazole
4. Recent advances in the diagnosis and management of giardiasis
5. Single-dose tinidazole for the treatment of giardiasis
6. Treatment of giardiasis in children with quinacrine, metronidazole, tinidazole and ornidazole
7. Biliary tract dysfunction in giardiasis
8. A case presentation of chronic cholecystitis and duodenitis
9. Relation of giardiasis to abnormal intestinal structure and function in gastrointestinal immunodeficiency syndromes
10. Idiopathic late-onset immunoglobulin deficiency: Clinical observations in 50 patients
11. Structure and function of the gastrointestinal tract in primary immunodeficiency syndromes: A study of 39 patients
12. Small intestinal nodular lymphoid hyperplasia in patients with giardiasis and normal serum immunoglobulins
13. Malignant lymphoma of the small bowel associated with diffuse nodular lymphoid hyperplasia
14. Role of suppressor T cells in pathogenesis of common variable hypogammaglobulinaemia
15. Acure antibody responses to Giardia lamblia are depressed in patients with AIDS
16. Biliary giardiasis in a HIV patient
17. Rapid reinfection by Giardia lamblia after treatment in a hyperendemic Third World community
18. Antigairdial activity of isoflavones
19. Giardia lamblia in AIDS patients with diarrhea
20. Giardiasis in HIV: A possible role in patients with severe immune deficiency
21. Immune response to Giardia duodenalis
22. T-cell-dependent control of acute Giardia lamblia infections in mice
23. Clinical and immunologic analyses of 103 patients with common variable immunodeficiency
24. Enhanced apoptosis of T cells in common variable immunodeficiency (CVID): Role of defective CD28 co-stimulation
25. Zinc deficiency, depressed thymic hormones, and T lymphocyte dysfunction in patients with hypogammaglobulinemia
26. Combined metronidazole and quinacrine hydrochloride therapy for chronic giardiasis
27. Chronic giardiasis: Studies on drug sensitivity, toxin production, and host immune response
28. Experimental human infections with Giardia lamblia
29. Convulsions following intrapleural administration of quinacrine hydrochloride
30. Mepacrine induced hepatitis [letter]
31. Safety of nitroimidazoles
32. Convulsions induced by metronidazole treatment for Clostridium difficile-associated disease in chronic renal failure
33. Convulsions associated with high cumulative doses of metronidazole
34. Activity of the anthelmintic benzimidazoles against Giardia lamblia in vitro
35. Albendazole: A more effective antigiardial agent in vitro than metronidazole or tinidazole
36. Albendazole and infections with Trichuris trichiura and Giardia intestinalis
37. Albendazole as a treatment for infections with Giardia duodenalis in children in Bangladesh
38. A randomised multicentre study to compare the safety and efficacy of albendazole and metronidazole in the treatment of giardiasis in children
39. Effect of twenty-three chemotherapeutic agents on the adherence and growth of Giardia lamblia in vitro
40. Isoprenylation of proteins in the protozoan Giardia lamblia
41. Antiamoebic and antigiardial activity of plant fiavonoids
42. Effects of paraomomycin sulfate in man against Entamodeba histolytica and other intestinal protozoa
43. Chemotherapy for giardiasis: Randomized clinical trial of bacitracin, bacitracin zinc, anda combination of bacitracin zinc with neomycin
44. Effect of d-propranolol on growth and motility of flagellate protozoa
45. Propranolol and metronidazole for the treatment of metronidazole-resistant giardiasis
46. The activity of drugs against Giardia intestinalis in neonatal mice
47. Efficacies of zinc-finger-active drugs against Giardia lamblia
48. Efficacy of fenbendazole for treatment of giardiasis in calves
49. Efficacy of fenbendazole in the treatment of experimental Giardia infection in dogs
50. Giardia lamblia: In vitro sensitivity to some chemotherapeutic agents
51. Heterogeneity in the sensitivity of stocks and clones of Giardia to metronidazole and ornidazole
52. Chemotherapy in giardiasis: Clinical responses and in vitro drug sensitivity of human isolates in axenic culture
53. Drug resistance in Giardia intestinalis
54. Inhibition of pyruvate-ferredoxin oxidoreductase gene expression in Giardia lamblia by a virus-mediated hammerhead ribozyme
55. Induction of metronidazole and furazolidone resistance in Giardia
56. Characterisation and purification of pyruvate: Ferredoxin oxidoreductase from Giardia duodenalis
57. TechLab and Alexon Giardia enzyme-linked immunosorbent assay kits detect cyst wall protein 1
58. Usefulness of an enzyme-linked immunosorbent assay for detection of Giardia antigen in feces